نتایج جستجو برای: itd mutation

تعداد نتایج: 292736  

Journal: :Journal of neurophysiology 2007
Brian J Fischer José Luis Peña Masakazu Konishi

Space-specific neurons in the barn owl's auditory space map gain spatial selectivity through tuning to combinations of the interaural time difference (ITD) and interaural level difference (ILD). The combination of ITD and ILD in the subthreshold responses of space-specific neurons in the external nucleus of the inferior colliculus (ICx) is well described by a multiplication of ITD- and ILD-depe...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Christophe Marzac I Teyssandier Ors'Anton Calendini Jean-Yves Perrot Anne-Marie Faussat Ruoping Tang Nicole Casadevall Jean-Pierre Marie Ollivier Legrand

PURPOSE Patients with adult acute myeloid leukemia (AML) with intermediate cytogenetics remain a heterogeneous group with highly variable individual prognoses. New molecular markers could help to refine cytogenetic stratification. EXPERIMENTAL DESIGN We assessed P-glycoprotein (Pgp) activity and Flt3 internal tandem duplication (ITD+) because of their known prognostic value and because they m...

2014
D L Stirewalt E L Pogosova-Agadjanyan K Tsuchiya J Joaquin S Meshinchi

Patients with high FLT3 internal tandem duplication allelic ratios (FLT3/ITD-ARs) have a poor prognosis. Single-nucleotide polymorphism/comparative genomic hybridization, single-cell PCR and colony-forming assays were used to evaluate genotypic evolution of high FLT3/ITD-ARs in 85 acute myeloid leukemia (AML) patients. Microarrays were used to examine molecular pathways disrupted in leukemic bl...

2016
Bianhong Wang Yangyang Liu Guangyuan Hou Lili Wang Na Lv Yuanyuan Xu Yihan Xu Xiuli Wang Zhaoling Xuan Yu Jing Honghua Li Xiangshu Jin Ailing Deng Li Wang Xiaoning Gao Liping Dou Junbin Liang Chongjian Chen Yonghui Li Li Yu

Intermediate-risk acute myeloid leukemia (IR-AML), which accounts for a substantial number of AML cases, is highly heterogeneous. Although several mutations have been identified, the heterogeneity of AML is uncertain because novel mutations have yet to be discovered. Here we applied next generation sequencing (NGS) platform to screen mutational hotspots in 410 genes relevant to hematological ma...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Chi-Kwong So Yan Nie Yunlong Song Guang-Yu Yang Suzie Chen Caroline Wei Li-Dong Wang Norman A Doggett Chung S Yang

PURPOSE Cyclic AMP response element binding protein binding protein (CBP), a nuclear transcriptional coactivator protein, is an important component of the cAMP signal transduction pathway. In this study, we systematically analyzed the pattern and frequency of CBP gene alterations in esophageal squamous cell carcinoma (ESCC) samples from Linzhou (Linxian), China. EXPERIMENTAL DESIGN Using micr...

Journal: :European thyroid journal 2016
Tetsuya Mizokami Shuji Fukata Akira Hishinuma Takahiko Kogai Katsuhiko Hamada Tetsushi Maruta Kiichiro Higashi Junichi Tajiri

BACKGROUND Iodide transport defect (ITD) is a dyshormonogenetic congenital hypothyroidism caused by sodium/iodide symporter (NIS) gene mutations. In the lactating mammary gland, iodide is concentrated by NIS, and iodine for thyroid hormone synthesis is thereby supplied to the infant in the breast milk. CASE DESCRIPTION A 34-year-old Japanese woman was diagnosed with ITD caused by a homozygous...

2005
Konstanze Döhner Richard F. Schlenk Marianne Habdank Claudia Scholl Frank G. Rücker Andrea Corbacioglu Lars Bullinger Stefan Fröhling

To assess the prognostic relevance of mutations in the NPM1 gene encoding a nucleocytoplasmic shuttle protein in younger adults with acute myeloid leukemia (AML) and normal cytogenetics, sequencing of NPM1 exon 12 was performed in diagnostic samples from 300 patients entered into 2 consecutive multicenter trials of the AML Study Group (AMLSG). Treatment included intensive double-induction thera...

Journal: :Blood 2005
Ksenia Bagrintseva Stefanie Geisenhof Ruth Kern Sabine Eichenlaub Carola Reindl Joachim W Ellwart Wolfgang Hiddemann Karsten Spiekermann

FLT3 (fms-like tyrosine kinase 3) is constitutively activated in about 30% of patients with acute myeloid leukemia (AML) and represents a disease-specific molecular marker. Although FLT3-LM (length mutation) and TKD (tyrosine kinase domain) mutations have been considered to be mutually exclusive, 1% to 2% of patients carry both mutations. However, the functional and clinical significance of thi...

Journal: :Blood 2005
Konstanze Döhner Richard F Schlenk Marianne Habdank Claudia Scholl Frank G Rücker Andrea Corbacioglu Lars Bullinger Stefan Fröhling Hartmut Döhner

To assess the prognostic relevance of mutations in the NPM1 gene encoding a nucleocytoplasmic shuttle protein in younger adults with acute myeloid leukemia (AML) and normal cytogenetics, sequencing of NPM1 exon 12 was performed in diagnostic samples from 300 patients entered into 2 consecutive multicenter trials of the AML Study Group (AMLSG). Treatment included intensive double-induction thera...

Journal: :Blood 2007
Deepa B Shankar Junling Li Paul Tapang J Owen McCall Lori J Pease Yujia Dai Ru-Qi Wei Daniel H Albert Jennifer J Bouska Donald J Osterling Jun Guo Patrick A Marcotte Eric F Johnson Niru Soni Kresna Hartandi Michael R Michaelides Steven K Davidsen Saul J Priceman Jenny C Chang Katrin Rhodes Neil Shah Theodore B Moore Kathleen M Sakamoto Keith B Glaser

In 15% to 30% of patients with acute myeloid leukemia (AML), aberrant proliferation is a consequence of a juxtamembrane mutation in the FLT3 gene (FMS-like tyrosine kinase 3-internal tandem duplication [FLT3-ITD]), causing constitutive kinase activity. ABT-869 (a multitargeted receptor tyrosine kinase inhibitor) inhibited the phosphorylation of FLT3, STAT5, and ERK, as well as Pim-1 expression ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید